Stay updated on Pembrolizumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Multiple Myeloma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:11:45.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, making the content inaccessible; the previous study details are replaced by the error message with a Home link available.
    Difference
    19%
    Check dated 2026-09-23T01:06:15.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.7.0, replacing the previous v3.6.6, indicating an internal update to the site’s versioning rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-09-16T00:12:35.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The Conditions section no longer displays 'Multiple Myeloma', and the MedlinePlus related topic entry 'MedlinePlus Genetics' (and the related topics header) has been removed.
    Difference
    0.2%
    Check dated 2026-09-08T22:32:49.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.6.5 to v3.6.6, indicating a minor site update. This change likely does not alter the study details or the information presented to users.
    Difference
    0.1%
    Check dated 2026-09-01T21:37:30.000Z thumbnail image
  8. Check
    54 days ago
    Change Detected
    Summary
    Added a line under Study Details showing '2015 ( U.S. NIH Grant/Contract )' to disclose NIH funding for the study. This provides contextual information about sponsorship without altering study criteria or outcomes.
    Difference
    0.1%
    Check dated 2026-08-25T23:25:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.